Crown Place VCT (CRWN) Competitors

Crown Place VCT (LON:CRWN) and The Biotech Growth Trust (LON:BIOG) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, community ranking, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

Which has more risk and volatility, CRWN or BIOG?

Crown Place VCT has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500. Comparatively, The Biotech Growth Trust has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.

Do analysts rate CRWN or BIOG?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Crown Place VCT	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
The Biotech Growth Trust	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Does the MarketBeat Community favor CRWN or BIOG?

Crown Place VCT received 5 more outperform votes than The Biotech Growth Trust when rated by MarketBeat users. Likewise, 65.91% of users gave Crown Place VCT an outperform vote while only 64.06% of users gave The Biotech Growth Trust an outperform vote.

Company	Underperform	Outperform
Crown Place VCT	Outperform Votes 87 65.91%	Underperform Votes 45 34.09%
The Biotech Growth Trust	Outperform Votes 82 64.06%	Underperform Votes 46 35.94%

Do insiders and institutionals hold more shares of CRWN or BIOG?

0.9% of Crown Place VCT shares are owned by institutional investors. Comparatively, 28.6% of The Biotech Growth Trust shares are owned by institutional investors. 0.1% of Crown Place VCT shares are owned by company insiders. Comparatively, 0.7% of The Biotech Growth Trust shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has higher earnings and valuation, CRWN or BIOG?

The Biotech Growth Trust has higher revenue and earnings than Crown Place VCT. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Crown Place VCT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Crown Place VCT	£4.18M	20.01	£2.11M	£0.01	2,980.00
The Biotech Growth Trust	£80.35M	4.23	£74.60M	£2.07	511.11

Does the media refer more to CRWN or BIOG?

In the previous week, The Biotech Growth Trust had 1 more articles in the media than Crown Place VCT. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for Crown Place VCT. The Biotech Growth Trust's average media sentiment score of 0.76 beat Crown Place VCT's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.

Company	Overall Sentiment
Crown Place VCT	Neutral
The Biotech Growth Trust	Positive

Is CRWN or BIOG more profitable?

The Biotech Growth Trust has a net margin of 92.85% compared to Crown Place VCT's net margin of 50.52%. The Biotech Growth Trust's return on equity of 21.57% beat Crown Place VCT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Crown Place VCT	50.52%	2.45%	1.52%
The Biotech Growth Trust	92.85%	21.57%	12.39%

Summary

The Biotech Growth Trust beats Crown Place VCT on 11 of the 15 factors compared between the two stocks.